No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-205622 ◽

2014 ◽

Vol 73 (11) ◽

pp. 2061-2062 ◽

Author(s):

Elizabeth V Arkema ◽

Nils Feltelius ◽

Tomas Olsson ◽

Johan Askling

Keyword(s):

Rheumatoid Arthritis ◽

Amyotrophic Lateral Sclerosis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Lateral Sclerosis ◽

Inhibitor Treatment

Download Full-text

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-201319 ◽

2012 ◽

Vol 72 (1) ◽

pp. 57-63 ◽

Author(s):

Lykke Midtbøll Ørnbjerg ◽

Mikkel Østergaard ◽

Pernille Bøyesen ◽

Niels Steen Krogh ◽

Anja Thormann ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Radiographic Progression ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Download Full-text

Faculty Opinions recommendation of Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108991.565450 ◽

2008 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Joint Damage ◽

Tumour Necrosis Factor Inhibitor ◽

Inadequate Response ◽

Structural Joint ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients

Annals of the Rheumatic Diseases ◽

10.1136/ard.2002.004226 ◽

2004 ◽

Vol 63 (3) ◽

pp. 318-320 ◽

Author(s):

C Pritchard

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Download Full-text

248 Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/key075.472 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Jonathan Massey ◽

Darren Plant ◽

Kimme Hyrich ◽

Ann W Morgan ◽

Anthony G Wilson ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Association Study ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Genome Wide Association Study ◽

Tumour Necrosis Factor Inhibitor ◽

Genome Wide Association ◽

Genome Wide ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment

British Journal of Dermatology ◽

10.1111/bjd.18869 ◽

2020 ◽

Vol 183 (1) ◽

pp. 7-8

Author(s):

T.‐F. Tsai

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Download Full-text

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-208490 ◽

2015 ◽

Vol 75 (4) ◽

pp. 785-786 ◽

Author(s):

L Dreyer ◽

M Magyari ◽

B Laursen ◽

R Cordtz ◽

F Sellebjerg ◽

...

Keyword(s):

Multiple Sclerosis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Tumour Necrosis Factor Inhibitor ◽

Population Based Study ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Download Full-text

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kes184 ◽

2012 ◽

Vol 51 (11) ◽

pp. 2020-2026 ◽

Author(s):

H. Canhao ◽

A. M. Rodrigues ◽

A. F. Mourao ◽

F. Martins ◽

M. J. Santos ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Comparative Effectiveness ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Predictors Of Response ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology ◽

10.1080/03009742.2020.1716992 ◽

2020 ◽

Vol 49 (3) ◽

pp. 253-255

Author(s):

H Matsuoka ◽

D Kabata ◽

A Taura ◽

T Matsui ◽

K Takahi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Single Nucleotide Polymorphism ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Japanese Patients ◽

Tumour Necrosis Factor Inhibitor ◽

Nucleotide Polymorphism ◽

Single Nucleotide ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

AB1304 Association between concomitant use of sulfasalazine and decrease of anti-ccp antibody levels in rheumatoid arthritis patients treated with tumour necrosis factor inhibitor or abatacept

10.1136/annrheumdis-2018-eular.1695 ◽

2018 ◽

Author(s):

H.-H. Chen ◽

D.-Y. Chen

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Antibody Levels ◽

Necrosis Factor

Download Full-text